EGFR and cancer: Although EGFR-TKI is an effective therapeutic agent, a long-term treatment with EGFR-TKI sometimes leads cancer cells into EGFR-TKI-tolerance[4,7,8], by which therapeutic options are probably reduced in cancer patients.